Mark W. Renshaw

2.1k total citations
31 papers, 1.8k citations indexed

About

Mark W. Renshaw is a scholar working on Molecular Biology, Hematology and Immunology and Allergy. According to data from OpenAlex, Mark W. Renshaw has authored 31 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Hematology and 6 papers in Immunology and Allergy. Recurrent topics in Mark W. Renshaw's work include Cell Adhesion Molecules Research (6 papers), Protein Kinase Regulation and GTPase Signaling (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Mark W. Renshaw is often cited by papers focused on Cell Adhesion Molecules Research (6 papers), Protein Kinase Regulation and GTPase Signaling (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Mark W. Renshaw collaborates with scholars based in United States, United Kingdom and Netherlands. Mark W. Renshaw's co-authors include Martin A. Schwartz, Paul E. Hughes, Mark H. Ginsberg, Martin Pfaff, Jane Forsyth, Leo Price, Jean Y. J. Wang, Deniz Toksoz, Jean M. Lewis and John R. McWhirter and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Mark W. Renshaw

31 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark W. Renshaw United States 19 1.0k 730 478 289 273 31 1.8k
Tatiana V. Kolesnikova United States 15 1.3k 1.3× 603 0.8× 346 0.7× 219 0.8× 150 0.5× 15 1.9k
Sandra Isenmann Australia 19 1.2k 1.2× 872 1.2× 205 0.4× 184 0.6× 309 1.1× 23 2.2k
Brigitte Boyer France 26 1.6k 1.6× 539 0.7× 768 1.6× 88 0.3× 853 3.1× 55 2.6k
Ikuko F. Mizukami United States 22 663 0.7× 319 0.4× 337 0.7× 362 1.3× 275 1.0× 27 1.5k
Eric Borges Germany 18 966 1.0× 1.3k 1.7× 227 0.5× 216 0.7× 599 2.2× 28 2.7k
L Fitz-Gibbon Canada 8 656 0.7× 773 1.1× 403 0.8× 97 0.3× 148 0.5× 13 1.3k
T. Venkat Gopal United States 11 811 0.8× 993 1.4× 126 0.3× 296 1.0× 210 0.8× 15 2.1k
Randolph S. Piotrowicz United States 13 608 0.6× 700 1.0× 333 0.7× 309 1.1× 114 0.4× 13 1.3k
Clare Rogers United States 15 784 0.8× 649 0.9× 122 0.3× 366 1.3× 311 1.1× 19 1.8k
P Laurila Finland 20 613 0.6× 238 0.3× 257 0.5× 132 0.5× 266 1.0× 37 1.7k

Countries citing papers authored by Mark W. Renshaw

Since Specialization
Citations

This map shows the geographic impact of Mark W. Renshaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Renshaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Renshaw more than expected).

Fields of papers citing papers by Mark W. Renshaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. Renshaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Renshaw. The network helps show where Mark W. Renshaw may publish in the future.

Co-authorship network of co-authors of Mark W. Renshaw

This figure shows the co-authorship network connecting the top 25 collaborators of Mark W. Renshaw. A scholar is included among the top collaborators of Mark W. Renshaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W. Renshaw. Mark W. Renshaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martínez‐Trufero, Javier, Giovanni Grignani, Sandra J. Strauss, et al.. (2023). 1922P Immunosarc II master trial: phase II of sunitinib and nivolumab in vascular sarcomas cohort - A GEIS, ISG and UCL study. Annals of Oncology. 34. S1034–S1034. 4 indexed citations
2.
Battat, Robert, Marjolijn Duijvestein, Niels Vande Casteele, et al.. (2018). Serum Concentrations of 7α-hydroxy-4-cholesten-3-one Are Associated With Bile Acid Diarrhea in Patients With Crohn’s Disease. Clinical Gastroenterology and Hepatology. 17(13). 2722–2730.e4. 30 indexed citations
3.
Smith, Matthew D., et al.. (2013). Qualitative analysis of factors leading to clinical incidents. International Journal of Health Care Quality Assurance. 26(6). 536–548. 4 indexed citations
4.
Allen, Joshua E., Roger Ferrini, David T. Dicker, et al.. (2012). Targeting TRAIL Death Receptor 4 with Trivalent DR4 Atrimer Complexes. Molecular Cancer Therapeutics. 11(10). 2087–2095. 25 indexed citations
5.
Grandea, Andres G., Ole Olsen, Thomas C. Cox, et al.. (2010). Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses. Proceedings of the National Academy of Sciences. 107(28). 12658–12663. 104 indexed citations
6.
Renshaw, Mark W., et al.. (2008). Clinical incident reporting: wrong time, wrong place. International Journal of Health Care Quality Assurance. 21(4). 380–384. 14 indexed citations
7.
Lin, Bing, et al.. (2008). A step-wise approach significantly enhances protein yield of a rationally-designed agonist antibody fragment in E. coli. Protein Expression and Purification. 59(1). 55–63. 20 indexed citations
8.
Renshaw, Mark W., et al.. (2006). Using patient and staff stories to improve risk management.. PubMed. 102(8). 34–6. 1 indexed citations
9.
Dakappagari, Naveen, Toshiaki Maruyama, Mark W. Renshaw, et al.. (2006). Internalizing Antibodies to the C-Type Lectins, L-SIGN and DC-SIGN, Inhibit Viral Glycoprotein Binding and Deliver Antigen to Human Dendritic Cells for the Induction of T Cell Responses. The Journal of Immunology. 176(1). 426–440. 39 indexed citations
10.
Perrin, Felicity, Mark W. Renshaw, & Charles Turton. (2003). Clinical decision-making and mechanical ventilation in patients with respiratory failure due to an exacerbation of COPD. Clinical Medicine. 3(6). 556–559. 5 indexed citations
11.
Renshaw, Mark W., et al.. (2002). A clinical risk profiling tool for trusts. International Journal of Health Care Quality Assurance. 15(3). 94–98. 1 indexed citations
12.
Ramos, Joe W., Paul E. Hughes, Mark W. Renshaw, et al.. (2000). Death Effector Domain Protein PEA-15 Potentiates Ras Activation of Extracellular Signal Receptor-activated Kinase by an Adhesion-independent Mechanism. Molecular Biology of the Cell. 11(9). 2863–2872. 62 indexed citations
13.
Renshaw, Mark W., Jean M. Lewis, & Martin A. Schwartz. (2000). The c-Abl tyrosine kinase contributes to the transient activation of MAP kinase in cells plated on fibronectin. Oncogene. 19(28). 3216–3219. 22 indexed citations
14.
Hughes, Paul E., Mark W. Renshaw, Martin Pfaff, et al.. (1997). Suppression of Integrin Activation: A Novel Function of a Ras/Raf-Initiated MAP Kinase Pathway. Cell. 88(4). 521–530. 442 indexed citations
15.
Renshaw, Mark W.. (1997). Growth factor activation of MAP kinase requires cell adhesion. The EMBO Journal. 16(18). 5592–5599. 265 indexed citations
16.
Meredith, Jere E., S Winitz, Jean M. Lewis, et al.. (1996). The Regulation of Growth and Intracellular Signaling by Integrins. Endocrine Reviews. 17(3). 207–220. 139 indexed citations
17.
Renshaw, Mark W., et al.. (1996). Rac is required for v-Abl tyrosine kinase to activate mitogenesis. Current Biology. 6(1). 76–83. 64 indexed citations
18.
Renshaw, Mark W., Deniz Toksoz, & Martin A. Schwartz. (1996). Involvement of the Small GTPase Rho in Integrin-mediated Activation of Mitogen-activated Protein Kinase. Journal of Biological Chemistry. 271(36). 21691–21694. 124 indexed citations
19.
Renshaw, Mark W., John R. McWhirter, & Jean Y. J. Wang. (1995). The Human Leukemia Oncogene bcr-abl Abrogates the Anchorage Requirement but Not the Growth Factor Requirement for Proliferation. Molecular and Cellular Biology. 15(3). 1286–1293. 76 indexed citations
20.
Renshaw, Mark W., et al.. (1988). Differential expression of type-specific c-abl mRNAs in mouse tissues and cell lines.. Molecular and Cellular Biology. 8(10). 4547–4551. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tatiana V. Kolesnikova Breakdown of academic impact, for papers by Sandra Isenmann Breakdown of academic impact, for papers by Brigitte Boyer Breakdown of academic impact, for papers by Ikuko F. Mizukami Breakdown of academic impact, for papers by Eric Borges Breakdown of academic impact, for papers by L Fitz-Gibbon Breakdown of academic impact, for papers by T. Venkat Gopal Breakdown of academic impact, for papers by Randolph S. Piotrowicz Breakdown of academic impact, for papers by Clare Rogers Breakdown of academic impact, for papers by P Laurila
Rankless by CCL
2026